Onderzoeker
Eline De Bruyne
- Trefwoorden:Pedagogische wetenschappen en didactiek
- Disciplines:Onderwijscurriculum, Onderwijssystemen, Algemene pedagogische en onderwijswetenschappen, Specialistische studies in het onderwijs, Andere pedagogische en onderwijswetenschappen
Affiliaties
- Centrum Academische Lerarenopleiding (Onderzoeksinstituut)
Lid
Vanaf1 nov 2005 → Heden
Publicaties
1 - 10 van 19
- Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts(2018)
Auteurs: Sylvia Faict, Josephine Muller, Kim De Veirman, Eline De Bruyne, Ken Maes, Louise Vrancken, Roy Heusschen, Hendrik De Raeve, Rik Schots, Karin Vanderkerken, et al.
- Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells [Oncotarget., 8, (2017), (52016-52025)] DOI: 10.18632/oncotarget.18152(2018)
Auteurs: N De Beule, E Menu, MJM Bertrand, M Favreau, Eline De Bruyne, K Maes, K De Veirman, M Radwanska, A Samali, S Magez, et al.
Pagina's: 22871 - Metabolic Features of Multiple Myeloma(2018)
Auteurs: Chaima El Arfani, Kim De Veirman, Ken Maes, Eline De Bruyne, Eline Menu
- DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells(2018)
Auteurs: Angelique Bruyer, Ken Maes, Laurie Herviou, Alboukadel Kassambara, Anja Seckinger, Guillaume Cartron, Thierry Reme, Nicolas Robert, Guilhem Requirand, Stephanie Boireau, et al.
Pagina's: 1062 - 1073 - Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression(2018)
Auteurs: Eva De Smedt, Ken Maes, Stefaan Verhulst, Hui Lui, Alboukadel Kassambara, Anke Maes, Nicolas Robert, Carlo Heirman, Andrew Cakana, Dirk Hose, et al.
Pagina's: 1155 - 1168 - Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects(2018)
Auteurs: Lien De Beck, Sarah Melhaoui, Kim De Veirman, Eline Menu, Eline De Bruyne, Karin Vanderkerken, Karine Breckpot, Ken Maes
- Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma(2017)
Auteurs: M Favreau, E Menu, D Gaublomme, K Vanderkerken, S Faict, K Maes, Eline De Bruyne, S Govindarajan, M Drennan, S Van Calenbergh, et al.
Pagina's: 2678 - 2685 - The therapeutic potential of cell cycle targeting in multiple myeloma(2017)
Auteurs: Anke Maes, Eline Menu, Kim De Veirman, Ken Maes, Karin Vanderkerken, Eline De Bruyne
Pagina's: 90501 - 90520 - Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion(2017)
Auteurs: Kim De Veirman, Nathan De Beule, Ken Maes, Eline Menu, Eline De Bruyne, Hendrik De Raeve, Karel Fostier, Jerome Moreaux, Alboukadel Kassambara, Dirk Hose, et al.
Pagina's: 839 - 846 - Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition(2017)
Auteurs: Meredis Favreau, Koen Venken, Sylvia Faict, Ken Maes, Kim De Veirman, Eline De Bruyne, Xavier Leleu, Louis Boon, Dirk Elewaut, Karin Vanderkerken, et al.
Pagina's: E266 - E270